Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Smiths Medical, part of the global technology business Smiths Group, has received 510(k) clearance from the FDA for its CADD-Solis Ambulatory Infusion System, a next generation ambulatory infusion platform that enhances patient safety and personalized care for pain management patients.
Subscribe to our email newsletter
Ambulatory infusion systems, like the CADD-Solis system, administer pain management medications, including narcotics, via a variety of delivery routes including intravenous and epidural.
Jim Stitt, president of Smiths Medical, said: “By involving both clinicians and the human factors engineering team at the University Health Network in Toronto in all phases of the development process, we strove to design a safe, easy-to-use system that brings exceptional value in helping hospitals reduce the risk of programming medication errors while providing better patient care management.”